UAE – Innovative diagnostics company Virax Biolabs Group Limited has opened its new regional headquarters in Dubai, solidifying its foothold the in the Middle East.
Located at the Dubai Science Park, the new office will continue Virax’s work in pushing forward the detection of immune responses and diagnosis of viral diseases.
This strategic move will accommodate the company’s expansion into the Middle East and improve global operations by attracting local partnerships and talents.
It builds on the mission of the Dubai Economic Agenda (D33) to make Dubai a hub for skilled workers, and the fastest-growing and most attractive global business centre.
In turn, this will further cement the emirate’s position as an international hub for global multinational companies (MNCs) and national small and medium-sized enterprises (SMEs).
Dubai has a proven track record as a global medical destination, securing the trust of patients and healthcare service providers globally.
In its official statement, Virax said: “The new headquarters will create new jobs and drive investment and talent to the UAE in line with the Dubai Economic Agenda.”
The renovated space will strengthen the company’s distribution network for its ViraxClear solutions as well as accelerate the development of innovative technologies behind Virax Immune tests.
Virax’s cutting-edge detection and treatment services will strengthen Dubai’s healthcare ecosystem and help achieve the vision of ‘We The UAE 2031’.
The Dubai office is strategically positioned in the heart of the global science-focused community dedicated to boosting progress in the pharma, health, and wellness sectors.
This news comes as innovative businesses are increasingly choosing Dubai Business Park to expand operations that benefit the lives and treatment of countless patients across the UAE and the wider Middle East region.
Dubai Science Park provides businesses with purpose-built infrastructure to foster growth and access to markets across the UAE as well as the MENA region.
AstraZeneca plans to construct sustainable offices at the Dubai Science Park as part of the biopharmaceutical giant’s global green agenda.
Backed by the TECOM Group, this space brings together an esteemed science and business community in a calm and peaceful environment to advance research, innovation, and businesses in the health, energy, and life sciences sectors.
Virax’s regional headquarters will help to increase its distribution reach of high-quality in-vitro diagnostics, innovative products, and proprietary T-Cell tests while creating logistical efficiencies.
“The opening of our regional headquarters in Dubai Science Park aligns perfectly with our mission to bring world-class testing solutions for viral threats to additional geographies,” asserted James Foster, Virax’s Chairman of the Board of Directors and Chief Executive Officer.
Moreover, becoming a part of Dubai Science Park aligns with Virax’s strategy and goal to establish global reach and enhance immune health and emerge as a fast-growing science company regionally and internationally.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
